Gene Therapy

ONK Therapeutics Presents Promising In-Vivo Data of its Optimized Affinity CD38 CAR-NK Candidate, Being Developed for the Treatment of Multiple Myeloma | DNA RNA and Cells

ONK Therapeutics Presents Promising In-Vivo Data of its Optimized Affinity CD38 CAR-NK Candidate, Being Developed for the Treatment of Multiple Myeloma Details Category: DNA RNA and Cells Published on Monday, 29 August 2022 13:24 Hits: 84 First in-vivo data for ONKT102, a fully human, optimized affinity CD38 CAR-NK cell therapy Data showed potent anti-tumor activity …

ONK Therapeutics Presents Promising In-Vivo Data of its Optimized Affinity CD38 CAR-NK Candidate, Being Developed for the Treatment of Multiple Myeloma | DNA RNA and Cells Read More »

New DNA repair vehicle used to fix a common genetic cause of hereditary kidney disease

Genetic mutations which cause a debilitating hereditary kidney disease affecting children and young adults have been fixed in patient-derived kidney cells using a potentially game-changing DNA repair-kit. The advance developed by University of Bristol scientists is published in Nucleic Acids Research. In this new study, the international team describe how they created a DNA repair …

New DNA repair vehicle used to fix a common genetic cause of hereditary kidney disease Read More »